iMDx posts Q2 loss as FDA review of GraftAssureDx continues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| BIO-RAD LABORATORIES (NYSE: BIO) | Delayed: 360.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $360.50 | 52 Week High | $174.02 | |||
| Open | $360.50 | 52 Week Low | $122.03 | |||
| Day High | $360.50 | P/E | 116.67 | |||
| Day Low | $360.50 | EPS | $3.09 | |||
| Volume | 2 | |||||
| (NASDAQ: IMDX) | Delayed: 3.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.02 | 52 Week High | $ | |||
| Open | $3.02 | 52 Week Low | $ | |||
| Day High | $3.02 | P/E | N/A | |||
| Day Low | $3.02 | EPS | $ | |||
| Volume | 9,364 | |||||
